Biosig Technologies (BSGM) Competitors $4.99 -0.28 (-5.31%) As of 02:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BSGM vs. BVS, ZIMV, AVNS, SMLR, KIDS, CBLL, TMCI, DCTH, BFLY, and RXSTShould you be buying Biosig Technologies stock or one of its competitors? The main competitors of Biosig Technologies include Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), Semler Scientific (SMLR), OrthoPediatrics (KIDS), CeriBell (CBLL), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Butterfly Network (BFLY), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Biosig Technologies vs. Its Competitors Bioventus ZimVie AVANOS MEDICAL Semler Scientific OrthoPediatrics CeriBell Treace Medical Concepts Delcath Systems Butterfly Network RxSight Biosig Technologies (NASDAQ:BSGM) and Bioventus (NASDAQ:BVS) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations. Which has more risk and volatility, BSGM or BVS? Biosig Technologies has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Is BSGM or BVS more profitable? Biosig Technologies has a net margin of 0.00% compared to Bioventus' net margin of -0.03%. Bioventus' return on equity of 23.04% beat Biosig Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Biosig TechnologiesN/A -5,336.99% -90.03% Bioventus -0.03%23.04%6.04% Do analysts prefer BSGM or BVS? Biosig Technologies currently has a consensus price target of $10.00, indicating a potential upside of 97.24%. Given Biosig Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Biosig Technologies is more favorable than Bioventus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biosig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Bioventus 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals have more ownership in BSGM or BVS? 7.2% of Biosig Technologies shares are held by institutional investors. Comparatively, 62.9% of Bioventus shares are held by institutional investors. 24.8% of Biosig Technologies shares are held by company insiders. Comparatively, 33.0% of Bioventus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer BSGM or BVS? In the previous week, Biosig Technologies had 1 more articles in the media than Bioventus. MarketBeat recorded 1 mentions for Biosig Technologies and 0 mentions for Bioventus. Biosig Technologies' average media sentiment score of 1.87 beat Bioventus' score of 0.00 indicating that Biosig Technologies is being referred to more favorably in the media. Company Overall Sentiment Biosig Technologies Very Positive Bioventus Neutral Which has stronger earnings & valuation, BSGM or BVS? Biosig Technologies has higher earnings, but lower revenue than Bioventus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiosig Technologies$40K3,982.49-$10.33MN/AN/ABioventus$573.28M1.07-$33.54MN/AN/A SummaryBiosig Technologies beats Bioventus on 9 of the 14 factors compared between the two stocks. Get Biosig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBiosig TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$159.14M$6.86B$5.75B$9.78BDividend YieldN/A1.29%4.40%4.04%P/E RatioN/A26.5430.5926.44Price / Sales3,982.4968.52383.3287.02Price / CashN/A21.5337.7259.11Price / Book-46.096.8510.106.65Net Income-$10.33M$176.42M$3.26B$265.42M7 Day Performance7.42%3.67%3.70%3.60%1 Month Performance5.85%-1.83%3.85%0.58%1 Year Performance1,167.18%8.94%38.01%19.65% Biosig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBiosig Technologies2.41 of 5 stars$4.99-5.3%$10.00+100.4%+1,077.7%$156.94M$40K0.0050Positive NewsBVSBioventus0.8908 of 5 stars$7.18-2.6%N/AN/A$609.34M$573.28M14.741,200ZIMVZimVie0.5051 of 5 stars$18.95+0.5%$17.75-6.3%+5.4%$531.59M$449.75M-27.071,770News CoverageAVNSAVANOS MEDICAL3.218 of 5 stars$11.24+0.4%N/A-51.1%$519.71M$687.80M-1.122,227Positive NewsSMLRSemler Scientific3.4531 of 5 stars$33.76-0.2%$81.75+142.2%+5.1%$500.99M$56.29M13.89120News CoverageKIDSOrthoPediatrics4.402 of 5 stars$19.20+0.1%$34.14+77.8%-30.5%$481.17M$220.73M-10.73200CBLLCeriBell2.2549 of 5 stars$12.18-1.1%$32.14+163.9%N/A$451.33M$65.44M-4.07N/APositive NewsTMCITreace Medical Concepts2.4222 of 5 stars$7.04+2.2%$9.83+39.7%+18.5%$435.26M$209.36M-8.91250DCTHDelcath Systems2.5796 of 5 stars$10.65+2.8%$24.50+130.0%+21.9%$362.41M$37.21M213.0060BFLYButterfly Network2.8248 of 5 stars$1.44+0.7%$3.00+108.3%+60.1%$359.99M$82.06M-5.14460Gap UpRXSTRxSight1.6257 of 5 stars$8.49+0.7%$10.00+17.8%-84.8%$344.92M$139.93M-10.61220 Related Companies and Tools Related Companies Bioventus Competitors ZimVie Competitors AVANOS MEDICAL Competitors Semler Scientific Competitors OrthoPediatrics Competitors CeriBell Competitors Treace Medical Concepts Competitors Delcath Systems Competitors Butterfly Network Competitors RxSight Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access